REVLON INC-CLASS A (REV) Fundamental Analysis & Valuation

NYSE:REV • US7615256093

Current stock price

3.8999 USD
-0.22 (-5.34%)
Last:

This REV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. REV Profitability Analysis

1.1 Basic Checks

  • In the past year REV has reported negative net income.
  • REV had a negative operating cash flow in the past year.
REV Yearly Net Income VS EBIT VS OCF VS FCFREV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 200M -200M -400M -600M

1.2 Ratios

Industry RankSector Rank
ROA -15.41%
ROE N/A
ROIC 8.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REV Yearly ROA, ROE, ROICREV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20 30

1.3 Margins

  • REV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.37%
PM (TTM) -18.74%
GM N/A
OM growth 3YN/A
OM growth 5Y-8.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REV Yearly Profit, Operating, Gross MarginsREV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

4

2. REV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so REV is still creating some value.
  • Compared to 1 year ago, REV has more shares outstanding
  • The debt/assets ratio for REV is higher compared to a year ago.
REV Yearly Shares OutstandingREV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
REV Yearly Total Debt VS Total AssetsREV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.2 Solvency

  • REV has an Altman-Z score of -0.60. This is a bad value and indicates that REV is not financially healthy and even has some risk of bankruptcy.
  • There is no outstanding debt for REV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.6
ROIC/WACC1.16
WACC7.62%
REV Yearly LT Debt VS Equity VS FCFREV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 1B -1B 2B -2B 3B

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that REV should not have too much problems paying its short term obligations.
  • REV has a Quick Ratio of 1.23. This is a bad value and indicates that REV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.75
REV Yearly Current Assets VS Current LiabilitesREV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

2

3. REV Growth Analysis

3.1 Past

  • REV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -124.11%.
  • Looking at the last year, REV shows a small growth in Revenue. The Revenue has grown by 0.61% in the last year.
  • REV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.29% yearly.
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-308.91%
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y-2.29%
Sales Q2Q%-11.02%

3.2 Future

  • Based on estimates for the next years, REV will show a decrease in Earnings Per Share. The EPS will decrease by -7.58% on average per year.
  • The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y-39.42%
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%
EPS Next 5Y-7.58%
Revenue Next Year3.47%
Revenue Next 2Y4.29%
Revenue Next 3Y3.95%
Revenue Next 5Y4.04%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
REV Yearly Revenue VS EstimatesREV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
REV Yearly EPS VS EstimatesREV Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4

0

4. REV Valuation Analysis

4.1 Price/Earnings Ratio

  • REV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REV Price Earnings VS Forward Price EarningsREV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.77
REV Per share dataREV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • REV's earnings are expected to decrease with -11.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%

0

5. REV Dividend Analysis

5.1 Amount

  • REV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REV Fundamentals: All Metrics, Ratios and Statistics

REVLON INC-CLASS A

NYSE:REV (10/20/2022, 8:11:10 PM)

3.8999

-0.22 (-5.34%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-09
Earnings (Next)11-08
Inst Owners0%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap228.40M
Revenue(TTM)2.06B
Net Income(TTM)-385.80M
Analysts45
Price Target8.67 (122.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-90.75%
Min EPS beat(2)-213.1%
Max EPS beat(2)31.59%
EPS beat(4)3
Avg EPS beat(4)80%
Min EPS beat(4)-213.1%
Max EPS beat(4)461.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.41%
Min Revenue beat(2)-13.62%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.66%
Min Revenue beat(4)-13.62%
Max Revenue beat(4)-1.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 1.77
EPS(TTM)-5.67
EYN/A
EPS(NY)-4.22
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS35.15
BVpS-40.09
TBVpS-55.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE N/A
ROCE N/A
ROIC 8.86%
ROICexc N/A
ROICexgc 21.69%
OM 8.37%
PM (TTM) -18.74%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.54%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.8%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.75
Altman-Z -0.6
F-Score4
WACC7.62%
ROIC/WACC1.16
Cap/Depr(3y)12.1%
Cap/Depr(5y)27.62%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-308.91%
EPS Next Y-39.42%
EPS Next 2Y-19.36%
EPS Next 3Y-11.19%
EPS Next 5Y-7.58%
Revenue 1Y (TTM)0.61%
Revenue growth 3Y-6.76%
Revenue growth 5Y-2.29%
Sales Q2Q%-11.02%
Revenue Next Year3.47%
Revenue Next 2Y4.29%
Revenue Next 3Y3.95%
Revenue Next 5Y4.04%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.53%
OCF growth 3YN/A
OCF growth 5YN/A

REVLON INC-CLASS A / REV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for REVLON INC-CLASS A?

ChartMill assigns a fundamental rating of 2 / 10 to REV.


What is the valuation status for REV stock?

ChartMill assigns a valuation rating of 2 / 10 to REVLON INC-CLASS A (REV). This can be considered as Overvalued.


Can you provide the profitability details for REVLON INC-CLASS A?

REVLON INC-CLASS A (REV) has a profitability rating of 1 / 10.


Can you provide the financial health for REV stock?

The financial health rating of REVLON INC-CLASS A (REV) is 2 / 10.


Can you provide the expected EPS growth for REV stock?

The Earnings per Share (EPS) of REVLON INC-CLASS A (REV) is expected to decline by -39.42% in the next year.